NASDAQ:BBH VanEck Biotech ETF - BBH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. $167.84 +0.10 (+0.06%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$164.91▼$168.2950-Day Range$157.28▼$170.1352-Week Range$131.12▼$170.25Volume9,883 shsAverage Volume15,042 shsMarket Capitalization$532.05 millionP/E RatioN/ADividend Yield0.45%Price TargetN/A ProfileChartDividendInstitutional OwnershipHeadlinesOptions ChainShort InterestSocial Media Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer Van Eck Fund NameVanEck Vectors Biotech ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Fund Statistics Assets Under Management$1.92 billion Average Daily Volume$14,048.50 Discount/Premium-1.27% ETF Expenses Management Fee0.35% Other Expenses0.04% Total Expenses0.39% Fee Waiver-0.04% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianThe Bank of New York Mellon Corporation DistributorVan Eck Securities Corporation Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerVirtu Financial Geographic Exposure of BBHCurrency Exposure of BBHSector Exposure of BBHIndustry Exposure of BBH Key CompetitorsAdams Natural Resources FundNYSE:PEOInvesco Municipal TrustNYSE:VKQInvesco Trust for Investment Grade MunicipalsNYSE:VGMInvesco California Value Municipal Income TrustNYSE:VCVBlackRock MuniHoldings California Quality FundNYSE:MUCView All CompetitorsInsiders & InstitutionsJanney Montgomery Scott LLCSold 1,050 shares on 2/1/2023Ownership: 0.206%Kestra Advisory Services LLCSold 1,668 shares on 1/31/2023Ownership: 0.579%Howard Wealth Management LLCBought 1,398 shares on 1/26/2023Ownership: 0.046%Cyndeo Wealth Partners LLCBought 1,300 shares on 1/25/2023Ownership: 0.042%Bullseye Investment Management LLCBought 11,147 shares on 1/24/2023Ownership: 0.363%View All Institutional Transactions BBH Stock - Frequently Asked Questions How have BBH shares performed in 2023? VanEck Biotech ETF's stock was trading at $159.74 at the start of the year. Since then, BBH stock has increased by 5.1% and is now trading at $167.84. View the best growth stocks for 2023 here. How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF? VanEck Biotech ETF announced an annual dividend on Friday, December 16th. Investors of record on Tuesday, December 20th will be given a dividend of $0.749 per share on Friday, December 23rd. This represents a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, December 19th. This is an increase from the stock's previous annual dividend of $0.40. Read our dividend analysis for BBH. Is VanEck Biotech ETF a good dividend stock? VanEck Biotech ETF (NASDAQ:BBH) pays an annual dividend of $0.75 per share and currently has a dividend yield of 0.45%. Read our dividend analysis for BBH. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX). What is VanEck Biotech ETF's stock symbol? VanEck Biotech ETF trades on the NASDAQ under the ticker symbol "BBH." Who are VanEck Biotech ETF's major shareholders? VanEck Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conservest Capital Advisors Inc. (0.66%), Kestra Advisory Services LLC (0.58%), Bullseye Investment Management LLC (0.36%), Aspiriant LLC (0.25%), Janney Montgomery Scott LLC (0.21%) and Blue Fin Capital Inc. (0.09%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is VanEck Biotech ETF's stock price today? One share of BBH stock can currently be purchased for approximately $167.84. How much money does VanEck Biotech ETF make? VanEck Biotech ETF (NASDAQ:BBH) has a market capitalization of $532.05 million. This page (NASDAQ:BBH) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.